Related Experiment Video
Updated: May 16, 2026

06:41
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes, 2013 update
Esther E Schmidt1, Oliver Pelz, Svetlana Buhlmann
1Division Signaling and Functional Genomics, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany.
Nucleic Acids Research
|November 30, 2012
Summary
The GenomeRNAi database now offers enhanced RNA interference (RNAi) data for human and Drosophila, improving gene function studies. This update features a redesigned interface, downloadable data, and improved integration with other biological resources.
Area of Science:
- * Genomics
- * Molecular Biology
- * Bioinformatics
Background:
- * RNA interference (RNAi) is crucial for large-scale loss-of-function studies to determine gene function.
- * The GenomeRNAi database compiles RNAi phenotype and reagent data from scientific literature for human and Drosophila.
- * Previous versions of the database have been published in the NAR Database Issue.
Purpose of the Study:
- * To describe the significant update of the GenomeRNAi database.
- * To introduce a redesigned user interface for improved usability and functionality.
- * To enhance data accessibility and integration with external resources.
Main Methods:
- * Re-design of the user interface for intuitive navigation and flexibility.
- * Implementation of data download for screen information and gene-reagent-phenotype associations.
- * Integration with external resources via GenomeRNAi screen IDs and gene/reagent identifiers.
- * Development of a Distributed Annotation System (DAS) server for genome browser visualization.
- * Addition of a 'frequent hitters' page to highlight consistently phenotyped genes.
- * Establishment of structured annotation guidelines and a data submission template.
Main Results:
- * A completely re-designed, user-friendly interface for the GenomeRNAi database.
- * Availability of downloadable screen information and gene-reagent-phenotype associations.
- * Improved interoperability with other biological databases and resources.
- * Enhanced visualization of RNAi phenotypes and reagents within genome browsers.
- * Identification of 'frequent hitter' genes across multiple screens.
- * Standardized curation through new annotation guidelines and a submission template.
Conclusions:
- * The updated GenomeRNAi database provides a more robust and accessible platform for RNAi research.
- * Enhanced data sharing and integration facilitate systematic gene function analysis.
- * New features support ongoing RNAi studies and promote consistent data curation.
Related Concept Videos
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

